NAD+ Injections for Texas Medical Practices: Supply & Compliance
Texas clinics offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what Texas providers need to know about ordering NAD+ for their practice.
NAD+ (nicotinamide adenine dinucleotide) therapy has moved from the fringes of functional medicine into the mainstream of medical practice offerings across Texas. From Houston's large network of longevity and anti-aging clinics to Dallas-Fort Worth's growing medical spa industry and Austin's functional medicine community, Texas providers are increasingly offering NAD+ subcutaneous injections as a core service.
If you operate a licensed medical practice in Texas and you're looking to add or expand NAD+ therapy, this guide covers what Texas providers need to know about supply, compliance, and ordering.
Why Texas Clinics Are Adding NAD+ Injections
NAD+ is a coenzyme found in every cell of the body, playing a central role in energy metabolism, DNA repair, and cellular signaling. NAD+ levels decline with age, and this decline has been linked to metabolic dysfunction, cognitive decline, reduced energy, and accelerated aging.
Subcutaneous NAD+ injections offer several advantages over IV infusions for clinic operations:
- Faster administration β Subcutaneous injections take minutes vs. hours for IV infusions
- No infusion suite required β Practices can offer NAD+ without dedicated IV infrastructure
- Patient self-administration β Some protocols allow patients to self-administer at home
- Lower overhead β Reduced chair time and nursing requirements compared to IV
Texas clinics offering NAD+ subcutaneous injections are seeing strong patient demand, particularly from patients already enrolled in GLP-1 programs who are interested in comprehensive metabolic and longevity protocols.
NAD+ Supply for Texas Clinics: What to Look For
Not all NAD+ supply is equal. Texas providers should source NAD+ from suppliers that meet the following standards:
USA cGMP Manufacturing β NAD+ for injection must be manufactured in a cGMP-compliant facility. MedClinic Partners supplies NAD+ manufactured exclusively in FDA-registered, USA-based cGMP facilities. We do not source from overseas manufacturers.
USP <797> Sterile Compounding β Injectable NAD+ must be compounded under USP <797> sterile conditions. Verify that your supplier's facility holds current USP <797> compliance documentation.
Certificate of Analysis β Every lot of NAD+ should come with a third-party Certificate of Analysis confirming identity, potency, sterility, and endotoxin levels. MedClinic Partners provides full CoA documentation through the portal for every order.
Lot Traceability β Full lot traceability from raw material to finished product is essential for Texas practices that may be subject to TSBP or TDSHS inspections.
Texas Regulatory Considerations for NAD+ Therapy
Prescribing Requirements β NAD+ subcutaneous injections require a valid prescription from a licensed Texas provider. Texas requires a valid patient-provider relationship for prescribing compounded medications, including NAD+.
Storage Requirements β Compounded NAD+ injectables require refrigeration at 2β8Β°C. Texas practices must maintain compliant medication storage logs.
TSBP Compliance β The Texas State Board of Pharmacy oversees compounding pharmacy operations in Texas. Practices sourcing NAD+ from out-of-state 503B facilities should ensure those facilities hold current FDA registration.
NAD+ Protocols Texas Clinics Are Running
Texas practices are offering NAD+ in a variety of clinical contexts:
Longevity and Anti-Aging Programs β NAD+ is a cornerstone of longevity medicine protocols. Texas longevity clinics typically offer NAD+ as part of comprehensive programs that may include GLP-1s, peptides, hormone optimization, and lifestyle interventions.
GLP-1 + NAD+ Combination Protocols β Many Texas clinics are pairing NAD+ with compounded semaglutide or tirzepatide. The combination supports mitochondrial function and energy metabolism, which can be particularly beneficial for patients experiencing fatigue during GLP-1 titration.
Cognitive and Performance Protocols β Texas concierge medicine and executive health practices are offering NAD+ for cognitive performance, focus, and energy optimization.
Post-Procedure Recovery β Some Texas surgical and aesthetic practices are incorporating NAD+ into post-procedure recovery protocols.
How MedClinic Partners Supplies NAD+ to Texas Clinics
MedClinic Partners supplies USA cGMP NAD+ subcutaneous injections to licensed medical practices throughout Texas β Houston, Dallas-Fort Worth, San Antonio, Austin, El Paso, and throughout rural Texas.
Same-Day Portal Access β Texas providers can apply and receive portal access within 24 hours of NPI verification. NAD+ is available through the same portal as our GLP-1 and peptide products.
Overnight Delivery β All orders ship overnight in temperature-controlled packaging to maintain the cold chain throughout transit.
Transparent Wholesale Pricing β No hidden fees, no mandatory bundles. Wholesale pricing is available immediately through the portal.
Getting Started
Texas clinics can apply online and receive portal access within 24 hours. Submit your NPI, Texas license information, and practice details through our portal. Verification typically completes within hours, and you'll have access to our full product catalog β NAD+, compounded GLP-1s, and USA cGMP RUO peptides β with transparent wholesale pricing.
Explore Topics
Written by
Shannon B.
Director of Provider Relations β GLP-1 & Compounding Specialist
Shannon leads provider relations at MedClinic Partners, working directly with licensed medical practices across all 50 states to onboard them onto the 503A/503B and peptide portal. She specializes in GLP-1 therapy protocols, NPI verification workflows, cGMP facility compliance, and cold-chain logistics for refrigerated compounded medications.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.